27-Jun-2019

Dr James Garner provides comprehensive GDC-0084 update to Morgans

Our CEO, Dr James Garner recently sat down with Morgans Senior Analyst Scott Power to provide a comprehensive update on our ongoing trials for our lead candidate, GDC-0084.

26-Jun-2019

Media coverage of DIPG researcher, Professor Matt Dun for World Brain Tumour Day

Professor Matt Dun was interviewed across leading broadcast and print media about his research into DIPG, a rare but aggressive form of childhood brain cancer.

24-Jun-2019

June 2019 Shareholder Newsletter

Kazia Therapeutics is pleased to make its June 2019 newsletter available to investors.

11-Jun-2019

World Brain Tumour Day: Enhancing awareness of the devastating childhood brain cancer, DIPG

Dr Matt Dun, a leading cancer researcher, discusses his research into Diffuse Intrinsic Pontine Glioma (DIPG) and GDC-0084.